Cemma Medical Co.

What Cemma Medical Co. does

Cemma Medical Co. (前茂企业) is a privately-held Greater China medical device distribution company founded in Taipei in 1980, with its operational headquarters in Shanghai and an additional Taipei branch. The company serves as the exclusive or primary distributor in China for a portfolio of international medical device brands, organized into five clinical areas: anesthesiology and ICU, respiratory care, nursing/vascular access, assisted reproduction, and renal/oncology treatment. Its core technology franchise is the PulsioFlex hemodynamic monitoring platform, which integrates OEM-licensed modules (PiCCO transpulmonary thermodilution, ProAQT pulse contour analysis, CeVOX spectrophotometric ScvO2 monitoring, and LiMON non-invasive ICG liver function testing) sourced primarily from Pulsion/Getinge; the supporting product range spans Bivona and Portex airway consumables, Wallace IVF catheters, PICC and PORT vascular access devices, hemodialysis catheters, Sofnolime CO2 absorbents, and Pall Ultipor breathing circuit filters.

The business model is B2B medical device distribution to hospitals, generating revenue through hardware sales of capital equipment and consumables (with pricing conducted on a quote basis via direct sales engagement) complemented by clinical application support services including pre-sales training, hospital department meetings, on-site clinical engineering support, and post-sales consultation. Cemma reaches 1,000+ hospitals across all 31 provinces/autonomous regions of China through a hybrid go-to-market: 20+ directly-operated branches organized into four regional profit centers (East, South, Southwest, North/Northwest), supplemented by 35+ authorized sub-dealers, with clinical training and academic conference participation (CSCCM, Chinese Society of Anesthesiology, reproductive medicine conferences) forming the core demand-generation mechanism. Headcount stands at 300+ direct employees; the company holds ISO 9002 (1999) and ISO 9001-2000 (2000) certifications, is led by Chairman Zhang Lianghua and CEO/GM Hou Fuxiang, and is privately owned with no disclosed external funding or parent entity.

Name

Cemma Medical Co.

Legal name

Cemma Medical Co. (前茂企业)

Website

https://cemma.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

251–500 employees

Short description

Cemma Medical Co. (前茂企业) is a privately-held Greater China medical device distributor, founded 1980 in Taipei, that exclusively represents international brands in hemodynamic monitoring, airway management, assisted reproduction, vascular access, and renal care across 1,000+ Chinese hospitals via 20+ branches and 35+ sub-dealers.

Ownership category

akta.pro rank

Headquarters

HQ city

Taipei

HQ country

Taiwan

HQ region

Asia

Offices15 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Medical Device Distribution: Cemma Medical operates as a sales agent and distributor for international medical device brands in Greater China. Revenue is generated through the sale of medical devices, consumables, and related products including hemodynamic monitoring equipment, airway management products, assisted reproduction supplies, and renal care products. The company acts as a bridge between international manufacturers and end customers in hospitals.
2. Clinical Application Support Services: Provides comprehensive pre-sales and post-sales services including product training, hospital seminars, on-site clinical support, and technical consultation as part of the value proposition to healthcare institutions.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Cemma Medical Co. is a sales promotion agent and exclusive distributor for international medical device manufacturers in Greater China, supplying hemodynamic monitoring platforms, airway management consumables, assisted reproduction devices, vascular access catheters, and renal/tumor treatment products to hospitals. The company pairs product distribution with pre-sales clinical training, hospital seminars, on-site application support, and post-sales consultation across its national branch network.

Product overview

Cemma Medical Co. is a medical device distribution company that serves as a sales promotion agent for international medical brands in Greater China, with over 40 years of history. The company's product portfolio centers on five clinical areas: Anesthesiology & ICU, Respiratory, Nursing, Assisted Reproduction, and Renal & Tumor Treatment. The core monitoring platform is the PulsioFlex 血流动力学监测平台 (PulsioFlex Hemodynamic Monitoring Platform), an expandable modular system that integrates multiple hemodynamic monitoring technologies including PiCCO Technology (transpulmonary thermodilution combined with arterial pulse contour analysis), ProAQT Technology (pulse contour analysis for continuous cardiac output), CeVOX Technology (central venous oxygen saturation monitoring), and LiMON Technology (non-invasive liver function assessment via ICG clearance). Supporting these platforms are peripheral sensors and catheters. The airway management portfolio includes percutaneous tracheostomy kits, emergency cricothyroidotomy sets (PCK), Bivona silicone tracheostomy tubes, endotracheal tubes (reinforced, suction above cuff, bronchial double-lumen), and carbon dioxide absorbents (SOLO碱石灰, Sofnolime钠石灰). The assisted reproduction line features Wallace embryo transfer catheters (Sure-Pro / Sure-Pro Ultra), Wallace IUI artificial insemination catheters, and Wallace oocyte recovery systems. Vascular access products include neonatal and adult PICC catheters (Pro-PICC for high-pressure CT contrast, Vascu-PICC), PORT implantable drug delivery systems, and temporary/long-term hemodialysis catheters (Side by side, Dop-split, Duo-Flow, HFS, SST, THD series). Additional respiratory accessories include artificial nose heat-moisture exchangers and Pall Ultipor breathing circuit filters. The company distributes products from international partners including icumed (Portex, acapella, Bivona, Medex), Getinge (PulsioFlex, PiCCO, NAVA), Medcomp, CooperSurgical (Wallace), Molecular Products (Sofnolime), and Danaher/Pall.

Differentiator

Problem solved

Functional benefit

Products and services

• PulsioFlex Hemodynamic Monitoring Platform (PulsioFlex 血流动力学监测平台) An expandable modular monitoring platform integrating PiCCO, ProAQT, CeVOX, and LiMON technologies for personalized hemodynamic monitoring in perioperative and intensive care settings, targeted at anesthesia and ICU departments in hospitals.
• PiCCO Technology (PiCCO 技术) Combined transpulmonary thermodilution and arterial pulse contour analysis technology for hemodynamic and volume monitoring, providing cardiac output, preload volume parameters, and extravascular lung water measurements for ICU and critical care use.
• ProAQT Technology (ProAQT 技术) Pulse contour analysis method providing continuous cardiac output, vascular resistance, myocardial contractility, and volume responsiveness via standard arterial catheter for early identification of hemodynamic instability.
• CeVOX Technology (CeVOX 技术) Spectrophotometric continuous monitoring of central venous oxygen saturation (ScvO2) with integrated oxygen delivery and consumption calculations as an add-on module to the PulsioFlex platform.
• LiMON Technology (LiMON 技术) Non-invasive liver function assessment using indocyanine green (ICG) clearance testing via pulse dye densitometry for hepatic reserve evaluation as an add-on module to the PulsioFlex platform.
• LogiCal Pressure Transducer (LogiCal 压力传感器) Microchip-based reusable pressure sensor with single-use transducer for arterial and venous pressure monitoring with integrated calibration.
• Percutaneous Tracheostomy Kit (经皮气管切开套装) Seldinger-based percutaneous tracheostomy kits including clamp dilation and horn-shaped dilation types for airway establishment.
• Emergency Cricothyroidotomy Kit / PCK (急诊环甲膜切开套装) Emergency cricothyroidotomy kit with Veress needle design for rapid artificial airway establishment in emergency situations, completing placement in 30-45 seconds.
• Bivona Silicone Tracheostomy Tube (Bivona硅胶气切插管) Silicone tracheostomy tubes including uncuffed, TTS water cuff, Aire-Cuf cuffed, and adjustable flange reinforced options for neonatal, pediatric, and adult patients.
• Endotracheal Tubes (气管插管) Endotracheal tubes including pediatric uncuffed, cuffed, nasal, special shaped, reinforced, and suction above cuff types.
• Blue Line Ultra Suction Tracheostomy Tubes (吸痰式气切)

Quantifiable outcome

• Products applied in over 1,000 hospitals across China
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

13 partnerships are on record, tiered major and core.

• Pall (Danaher)majorChannel Partner/ Reseller/ Distributor · 1 January 2022Exclusive distributor for Pall breathing circuit filters since 2022, including Ultipor series respiratory pathway filters for anesthesia and ventilation equipment.
• Getinge (NAVA)majorChannel Partner/ Reseller/ Distributor · 1 January 2019Exclusive distributor for NAVA diaphragm catheter under Maquet/GETINGE group since 2019.
• ConglaymajorChannel Partner/ Reseller/ Distributor · 1 January 2019Exclusive distributor for Conglay cuff pressure monitor products since 2019.
• Smiths Medical (acapella)majorChannel Partner/ Reseller/ Distributor · 1 January 2017Exclusive distributor for acapella vibration positive pressure ventilation therapy system since 2018.
• Molecular ProductscoreChannel Partner/ Reseller/ Distributor · 1 January 2000Exclusive distributor for Sofnolime CO2 absorbents for anesthesia machines since 2000.
• Wallace (CooperSurgical)coreChannel Partner/ Reseller/ Distributor · 1 January 1998Exclusive distributor for Wallace assisted reproduction products including embryo transfer catheters, oocyte collection systems since 1998.
• Pulsion Medical Systems AG (Getinge)coreChannel Partner/ Reseller/ Distributor · 1 January 1997Exclusive distributor for PiCCO hemodynamic monitoring products since 1997. Introduced PiCCO technology to China, serving ICU and critical care applications.
• Smiths Medical (Portex)coreChannel Partner/ Reseller/ Distributor · 1 January 1994Exclusive distributor for PORTEX airway management products since 1994, including endotracheal tubes, tracheostomy tubes, and respiratory products.
• Arrow International, Inc.coreChannel Partner/ Reseller/ Distributor · 1 January 1983Exclusive distributor relationship established in 1983, introduced Seldinger puncture technology to Chinese market. Arrow International specializes in vascular access and critical care products.
• icu medicalmajorChannel Partner/ Reseller/ DistributorPartnership for PORTEX and Level 1 warming products including infusion/blood warmers. Participated jointly in CMEF exhibitions.
• MedcompcoreChannel Partner/ Reseller/ DistributorPartnership for vascular access and hemodialysis catheter products.
• CooperSurgicalcoreChannel Partner/ Reseller/ DistributorJoint exhibitions and marketing at reproductive medicine conferences for Wallace, Humagen, and RI brand series products.
• GetingecoreChannel Partner/ Reseller/ DistributorPartnership for PulsioFlex hemodynamic monitoring platform and PiCCO technology products. Cemma participates in Getinge Experience Center (GEC) training programs.

Scale indicators5 records

Recent moves11 records

Expansion highlights5 records

Others

• Getinge: Swedish medtech major and Cemma's exclusive partner for PiCCO and PulsioFlex hemodynamic monitoring since 1997. Comparable as the upstream principal whose products Cemma distributes; relevant as the principal whose strategic decisions directly shape Cemma's portfolio.

Direct peers

• Sonoscape: Shenzhen-based medical device manufacturer with patient monitoring and in-vitro diagnostics lines. Competes with Cemma's hemodynamic monitoring offerings in mid-tier Chinese hospitals as a lower-priced domestic alternative.
• MicroPort Scientific: Shanghai-based medical device group with cardiovascular, orthopedic, and endovascular portfolios that overlap with Cemma's vascular access and critical care product categories. Operates its own direct sales force in China across the same hospital channels.
• Edan Instruments: Shenzhen-based medical device manufacturer with patient monitoring, ECG, and OB/GYN product lines. Competes directly with Cemma-distributed hemodynamic monitoring brands in Chinese hospitals, particularly in tier-2 and tier-3 facilities.
• Mindray (Shenzhen Mindray Bio-Medical Electronics): China's largest domestic medical device company, directly competing with Cemma's hemodynamic monitoring, patient monitoring, and airway management offerings. Mindray is both a manufacturer and direct seller to hospitals — overlapping with Cemma's product lines but competing as the local alternative to the imported brands Cemma distributes.

Broad incumbents

• Edwards Lifesciences: US-based global leader in hemodynamic monitoring and critical care. Competes head-to-head with the PiCCO/PulsioFlex platform that Cemma distributes in China, particularly in cardiac surgery and ICU applications.
• Medtronic: Global medtech incumbent with established direct operations in China spanning patient monitoring, airway, vascular, and renal products — overlapping with most of Cemma's clinical verticals, particularly vascular access and critical care.
• Drägerwerk: German global leader in anesthesia workstations, ventilators, and patient monitoring. Directly overlaps with Cemma's anesthesia/ICU and respiratory portfolio, including competing solutions for the airway management and monitoring products Cemma distributes from Smiths Medical and Getinge.
• Becton Dickinson (BD): US-based global medtech company with direct China operations in vascular access, infusion therapy, and critical care consumables — directly overlapping with Cemma's PICC, PORT, and dialysis catheter portfolio from Medcomp and Arrow.

Regional players

• Nipro Corporation: Japan-based medical device company with a major hemodialysis and vascular access portfolio. Comparable to Cemma's renal/tumor treatment segment (hemodialysis catheters, PORT systems) but competes from Japan across Asia rather than from within Greater China.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cemma Medical Co.